ArticleKidney international reports2017
Commercial Kidney Transplantation: Attitude, Knowledge, Perception, and Experience of Recipients.
Article in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis.ESC heart failure · 2021Pooled it
- Informing national policy: Healthcare workers' readiness for a deceased donor kidney transplant program in Brunei Darussalam.World journal of transplantation · 2026Article
- Paid Organ Donation: Case Report and Review of the Literature on Health Implications for Kidney Donors and Recipients.Pathogens (Basel, Switzerland) · 2025Review
- Ending the organ trade: an ethical assessment of regulatory possibilities.Monash bioethics review · 2025Article
- Knowledge, attitude, and practice of kidney transplant patients regarding post-transplant complications: a cross-sectional study.Translational andrology and urology · 2025Article
- Evaluating ATG Induction Therapy Outcomes After Commercial Kidney Transplantation: Insights from a Tertiary Hospital Experience.Journal of clinical medicine · 2025Article
- Dilemma of commercial organ transplant in the Middle East.BMC medicine · 2024Article
- Deceased donor kidney transplant policies in Asia - implications on practice and recommendations for the future.The Lancet regional health. Southeast Asia · 2024Review
- Baseline Ethical Principles and a Framework for Evaluation of Policies: Recommendations From an International Consensus Forum.Transplantation direct · 2023Article
- Mycophenolate Induced Colitis: One-year Post-kidney Transplantation.Oman medical journal · 2023Article
- Infectious Complications of Transplant Tourism.Current infectious disease reports · 2019Review
- Characteristics of Burden, Coping Strategies, and Quality of Life: The Effect of Age, Gender, and Social Variables in Caregivers of Renal Transplanted Patients from Southern Andhra Pradesh, India.Indian journal of palliative careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionKidney transplantation is the gold standard for patients with end-stage kidney disease. In view of shortages of available organs, long wait times for possible transplantation, and strict regulation, many patients opt for commercial transplantation. This study elicits the reasons and motivations for patients with end-stage kidney disease to elect for commercial transplant.
methodsA questionnaire-based evaluation was conducted during the period from July 2015 until late December 2015. It consisted of 29 multiple choice questions and was distributed to all patients who underwent commercial kidney transplantation.
resultsOne hundred and fifty patients were approached to participate and 106 agreed. Of the participants, 60% were male with an average age of 41.5 (SD 14.8) years and ranged from 18 to 83 years. The majority (82%) of our participants were educated ranging from primary to college level. The major reason (71%) for these participants to obtain commercial transplants was stated as the unavailability of a live related donor. Thirteen percent stated that they objected to getting a kidney donated from a family member, and 9% stated that they were worried about taking a kidney from a family member. Finally, 3% of participants stated that they needed prompt transplant and could not wait for a long time for transplant investigations and the workup associated with this program. DISCUSSION: The study showed that the most common underlying cause for seeking commercial transplantation is the unavailability of a national transplant program, particularly transplantation from deceased sources. All western ethical arguments turn out to become of vital importance in developing countries, because transplantation is the cheapest renal replacement therapy. However, it must be emphasized that commercial transplants should not be an alternative to building a national transplant initiative. The national diseased program must be a priority with full financial and administrative support. All government agencies including religious affairs must work together to support the program and to provide the citizens with a good transplantation service and ameliorate the impact of commercial transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.